Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials.

Centre on Aging and Mobility, University of Zurich, University Hospital, Switzerland.
Archives of internal medicine (Impact Factor: 13.25). 04/2009; 169(6):551-61. DOI: 10.1001/archinternmed.2008.600
Source: PubMed

ABSTRACT Antifracture efficacy with supplemental vitamin D has been questioned by recent trials.
We performed a meta-analysis on the efficacy of oral supplemental vitamin D in preventing nonvertebral and hip fractures among older individuals (> or =65 years). We included 12 double-blind randomized controlled trials (RCTs) for nonvertebral fractures (n = 42 279) and 8 RCTs for hip fractures (n = 40 886) comparing oral vitamin D, with or without calcium, with calcium or placebo. To incorporate adherence to treatment, we multiplied the dose by the percentage of adherence to estimate the mean received dose (dose x adherence) for each trial.
The pooled relative risk (RR) was 0.86 (95% confidence interval [CI], 0.77-0.96) for prevention of nonvertebral fractures and 0.91 (95% CI, 0.78-1.05) for the prevention of hip fractures, but with significant heterogeneity for both end points. Including all trials, antifracture efficacy increased significantly with a higher dose and higher achieved blood 25-hydroxyvitamin D levels for both end points. Consistently, pooling trials with a higher received dose of more than 400 IU/d resolved heterogeneity. For the higher dose, the pooled RR was 0.80 (95% CI, 0.72-0.89; n = 33 265 subjects from 9 trials) for nonvertebral fractures and 0.82 (95% CI, 0.69-0.97; n = 31 872 subjects from 5 trials) for hip fractures. The higher dose reduced nonvertebral fractures in community-dwelling individuals (-29%) and institutionalized older individuals (-15%), and its effect was independent of additional calcium supplementation.
Nonvertebral fracture prevention with vitamin D is dose dependent, and a higher dose should reduce fractures by at least 20% for individuals aged 65 years or older.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D can be synthesized following exposure to ultraviolet radiation (UVR), ingested in the diet or provided through oral supplementation. The medical literature frequently states that humans obtain most of their vitamin D from sunshine and that UVR exposure is essential to maintain vitamin D levels. A systematic review was conducted to determine the requirement for UVR in maintaining adequate (> 50 nmol L−1) serum 25-hydroxyvitamin D [25(OH)D] levels. Studies reporting serum 25(OH)D during situations of negligible UVR exposure were sought. Forty-one studies (from a search yielding 42 698 articles) with a total of 4211 healthy adults met the inclusion criteria, providing 56 datasets from different population groups. Over 50% of subjects had > 50 nmol L−1 25(OH)D in 10 of 19 datasets reporting winter levels in areas with limited UVR. In addition, > 50% of subjects had adequate 25(OH)D levels in four of 12 datasets from polar regions during periods of negligible UVR, one of nine datasets documenting clothing-related minimal UVR and two of eight datasets detailing employment-related minimal UVR. The data demonstrate that many adults maintain adequate serum vitamin D levels despite negligible UVR exposure for several months. However, we acknowledge that preceding UVR exposure leading to vitamin D storage and delayed release may account for this maintenance of adequate serum vitamin D levels. There remains a need for further research on whether UVR exposure is required for longer-term maintenance of adequate vitamin D levels.
    British Journal of Dermatology 02/2015; 172(3). DOI:10.1111/bjd.13575 · 4.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Though vitamin D is important for bone health, little is known about the monitoring and management of vitamin D levels in patients with osteoporosis in clinical practice-a deficit this chart review initiative aimed to remedy. A total of 52 physicians completed profiles for 983 patients being treated for osteoporosis between November 2008 and April 2009. Information collected included demographics; fracture risk factors; availability and level of serum vitamin D measurements; and information on osteoporosis medications and calcium and vitamin D supplementation. Physicians also evaluated patients' current regimens and detailed proposed changes, if applicable. Nearly 85% of patients were prescribed calcium and vitamin D supplements. Serum 25-hydroxy vitamin D levels were available for 73% of patients. Of these patients, approximately 50% had levels less than 80 nmol/L, which contrasts with the 37% thought to have "unsatisfactory" vitamin D levels based on physician perceptions. Physicians felt 26% of patients would benefit from additional vitamin D supplementation. However, no changes to the osteoporosis regimen were suggested for 48% of patients perceived to have "unsatisfactory" vitamin D levels. The results underscore the importance of considering vitamin D status when looking to optimize bone health.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate type 1 diabetes as a risk factor for vitamin D status in an established, multi-ethnic adolescent cohort in relation to a healthy Canadian population.MethodsA total of 271 subjects, 12 to 18 years of age, with established type 1 diabetes mellitus, were recruited for this cross-sectional study. Demographic and clinical data were collected, and 25-hydroxyvitamin D (25-OHD) levels using liquid chromatography-mass spectrometry (LC-MS/MS) were measured. Normative Canadian-based population data were used as a reference group.ResultsLower rates of vitamin D sufficiency were observed in adolescents with type 1 diabetes when compared to healthy Canadian adolescents. For the type 1 diabetes group 14.0% of subjects were vitamin D sufficient (>75.0 nmol/L) and 32.8% were deficient (≤37.5 nmol/L), compared to 35.2% and 11.8%, respectively in the Canadian reference population (p<0.05). Caucasian subjects with type 1 diabetes had significantly higher vitamin D sufficiency levels (32.7%) compared to Hispanic (17.6%), South Asian (9.1%), Asian (7.1%), African-Canadian (4.2%) and mixed ethnicity (9.1%) groups (p<0.05). There was a strong association between ethnicity and vitamin D deficiency when adjusting for age, sex, body mass index (BMI) and glycated hemoglobin (A1C) (p<0.0001). Lastly, systolic blood pressure was higher in the vitamin D deficient group (p<0.05).Conclusions These results indicate that type 1 diabetes is an independent risk factor for vitamin D deficiency beyond initial diagnosis and that ethnicity plays a significant role. Given that adolescence is a critical period of accrual of bone mass and progression of diabetes complications, consideration should be given for promotion of a vitamin D fortified diet or routine supplementation particularly in visible minorities with type 1 diabetes.
    Canadian Journal of Diabetes 12/2012; 36(6):314-319. DOI:10.1016/j.jcjd.2012.10.002 · 0.46 Impact Factor

Preview (2 Sources)

Available from